Novartis to acquire UK-based ocular gene therapy company
Swiss pharmaceutical giant Novartis said Wednesday it was to acquire a UK-based biotech company developing gene therapies for eye diseases called Gyroscope Therapeutics.
source https://medicalxpress.com/news/2021-12-novartis-uk-based-ocular-gene-therapy.html
source https://medicalxpress.com/news/2021-12-novartis-uk-based-ocular-gene-therapy.html
Comments
Post a Comment